TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) — Federal Contracts & Tech Stack
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) is an active recipient of U.S. federal and defense procurement awards. According to federal procurement records and obligation filings, the company has been awarded 0 prime federal contracts and delivery orders totaling approximately $0 across 1 federal awarding agencies, with the most recent award action registered on —.
Federal contracts represent substantial multi-year revenue visibility for prime contractors and defense suppliers. Gemral Edge continuously reconciles federal award obligations from the Federal Procurement Data System (FPDS) and USAspending with congressional disclosures, tracking capital flow from policy authorization through corporate execution.
Quick Facts & Defense Contracting Direct Answers
How much does TEVA PHARMACEUTICAL INDUSTRIES LTD receive in federal government contracts?
TEVA PHARMACEUTICAL INDUSTRIES LTD has been awarded over $0 in tracked prime federal obligations across 1 awarding agencies, as recorded in official FPDS and USAspending data.
Which congressional lawmakers trade TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) stock?
Public Periodic Transaction Reports (PTR) under the STOCK Act record transactions in TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) by congressional lawmakers and affiliated accounts.
How are federal defense contracts mapped to TEVA PHARMACEUTICAL INDUSTRIES LTD on Gemral Edge?
Gemral Edge programmatically reconciles prime award obligations from SAM.gov, USAspending, and FPDS through corporate parent CAGE and UEI hierarchies directly to ticker TEVA.
Unified Ticker Intelligence Dossier (TEVA)
Synthesis: Mã TEVA ghi nhận dữ liệu hoạt động tổng hợp qua các kênh công quyền và dòng tiền.
Temporal Context: Dữ liệu các kênh hoạt động đang trong trạng thái theo dõi chu kỳ đối với TEVA.
Data Coverage & Verification: Overall coverage score: 33% across 6 pillars (Government, Policy, Flow, Management, Catalysts, Historical). Verified by 2 independent statutory data sources.
Congressional Stock Trading Activity in TEVA
Disclosed stock purchases and sales by members of Congress and spouses involving TEVA PHARMACEUTICAL INDUSTRIES LTD securities under the STOCK Act:
| Lawmaker | Party-State | Chamber | Transaction Date | Action | Disclosed Range | Est. Return |
|---|---|---|---|---|---|---|
| Greg Gianforte | R-MT | HOUSE | 2020-11-13 | BUY | $15K – $50K | +288.3% |
| Donna E. Shalala | D-FL | HOUSE | 2020-05-07 | SELL | $1K – $15K | +219.1% |
| Patty Murray | D-WA | SENATE | 2017-06-15 | SELL | $1K – $15K | +21.1% |
| Angus S. King, Jr. | I-ME | SENATE | 2016-10-19 | SELL | $1K – $15K | -15.0% |
| K. Michael Conaway | R-TX | HOUSE | 2016-09-12 | SELL | $1K – $15K | -28.5% |
| K. Michael Conaway | R-TX | HOUSE | 2016-05-04 | SELL | $1K – $15K | -31.5% |
| Thomas MacArthur | R-NJ | HOUSE | 2015-01-27 | SELL | $1K – $15K | -37.6% |
| K. Michael Conaway | R-TX | HOUSE | 2015-02-09 | SELL | $1K – $15K | -34.6% |
| Alan S. Lowenthal | D-CA | HOUSE | 2014-12-19 | BUY | $15K – $50K | -36.5% |
Related Congressional Committees & Active Lawmakers
Disclosed lawmakers and congressional committees holding policy jurisdiction, defense appropriations oversight, or direct capital exposure in TEVA:
- Greg Gianforte (House) — Disclosed STOCK Act transactions (R-MT)
- Donna E. Shalala (House) — Disclosed STOCK Act transactions (D-FL)
- Patty Murray (Senate) — Disclosed STOCK Act transactions (D-WA)
- Angus S. King, Jr. (Senate) — Disclosed STOCK Act transactions (I-ME)
- K. Michael Conaway (House) — Disclosed STOCK Act transactions (R-TX)
- Thomas MacArthur (House) — Disclosed STOCK Act transactions (R-NJ)
- Alan S. Lowenthal (House) — Disclosed STOCK Act transactions (D-CA)
- Nancy Pelosi (House) — Former Speaker of the House (D-CA)
Latest Real-Time Intelligence & Breaking Events
Live contract obligations, SEC filings, and procurement intelligence for TEVA PHARMACEUTICAL INDUSTRIES LTD are monitored 24/7 on Gemral Edge Breaking News and Defense Radar.
Federal Contracting Dynamics & Government Revenue Exposure
Government contracting for defense and enterprise infrastructure follows strict Federal Acquisition Regulation (FAR) guidelines, often spanning multi-year base periods with optional extension years. Monitoring prime contractor award velocity provides institutional investors and market participants with un-lagged visibility into backlog expansion, agency budget priorities, and defense authorization funding flows.
Furthermore, when members of congressional defense, intelligence, or appropriations committees disclose trading activity in major federal contractors such as TEVA PHARMACEUTICAL INDUSTRIES LTD, cross-referencing contract award timelines with legislative disclosures highlights important intersections of public policy and corporate performance.
Frequently asked questions
How much does TEVA PHARMACEUTICAL INDUSTRIES LTD receive in federal government contracts?
TEVA PHARMACEUTICAL INDUSTRIES LTD holds over $0 in tracked federal obligations across 1 public agencies, providing multi-year revenue visibility across defense and civilian procurement budgets.
Which congressional lawmakers trade TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) stock?
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) stock transactions have been disclosed by members of Congress. Disclosures filed under the STOCK Act detail execution dates, asset classes, and statutory valuation ranges.
How are federal defense contracts resolved to TEVA PHARMACEUTICAL INDUSTRIES LTD?
Gemral Edge maps prime award notices from the Federal Procurement Data System (FPDS) and USAspending through Ultimate Parent CAGE and UEI corporate hierarchies directly to parent ticker TEVA.
What technology stack signals are detected for TEVA PHARMACEUTICAL INDUSTRIES LTD?
Active talent hiring requisitions and engineering role profiles are continuously monitored across public corporate job postings to track enterprise software adoption and technology migration patterns.
Data intelligence from public filings — not investment advice.
Explore Gemral Edge
- Greg Gianforte — stock portfolio
- Donna E. Shalala — stock portfolio
- Patty Murray — stock portfolio
- Angus S. King, Jr. — stock portfolio
- K. Michael Conaway — stock portfolio
- Thomas MacArthur — stock portfolio
- Capitol Trades leaderboard
- Federal contract explorer
- Lobbying velocity index
- Live signal radar
- Macro & liquidity radar
- 2026 Senate battleground